glutathione pulmonary fibrosis Metabolic dysregulation in fibrosis: insights into amino acid contributions and therapeutic potential Comprehensive review of potential drugs

Permeability of the blood-brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis

Once the limit is reached, lipids begin to accumulate in ectopic non-adipose tissues [80]

[DOI] [PubMed] [Google Scholar] 135.Zhang Y.J., Wu Q

For targeting alveolar macrophages, mannose is widely utilized owing to its interaction with the macrophage mannose receptor 1 (also known as CD206) on macrophage surfaces, making it a popular choice in pulmonary drug delivery applications 221,222 , including LNPs 223 , solid LNPs 223,224 and other lipid nanoformulations 225

The newly developed ferroptosis inducing compound ferroptocide is a Trx inhibitor [96]

These results imply that targeting miR-100 pathways, particularly through anti-miR-100 therapy, could strategically reactivate mTOR in specific contexts, disrupting BCSC resistance mechanisms and sensitizing tumors to existing treatments